Effect of hepatitis B virus mutants on efficacy of vaccination (Q33903914)

29 July 2017

1 reference

title

Effect of hepatitis B virus mutants on efficacy of vaccination (English)

1 reference

29 July 2017

1 reference

1 reference

A J Zuckerman

1

1 reference

PubMed ID

10791517

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

29 July 2017

1 reference

29 July 2017

355

1 reference

29 July 2017

9213

1 reference

29 July 2017

1382-1384

1 reference

Vaccine-induced escape mutant of hepatitis B virus

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Molecular epidemiology of hepatitis B virus mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Immunoassay detection of hepatitis B surface antigen mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Molecular epidemiology of hepatitis B virus vaccine variants in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Natural history of hepatitis B surface antigen mutants in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Current status of HBV vaccine escape variants--a mathematical model of their epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

A new class of defective hepatitis B virus genomes with an internal poly(dA) sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902132-2

7 January 2021

10.1016/S0140-6736(00)02132-2

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10791517